A photo illustration show a syringe. Argentina was selected to test a vaccine against COVID -19, it is estimated that the clinical phases will be...
for its COVID-19 vaccine candidate in the UK.Novavax, in partnership with the UK Government's Vaccines Taskforce, will enroll up to 10,000 individuals in the trial over the next 4 to 6 weeks."The data from this trial is expected to support regulatory submissions for licensure in the UK, EU and other countries," Novavax said.
Read More:Europe is heading back into lockdown, but when travel resumes, these are the 3 European airline stocks to own, Morgan Stanley saysInvestors are likely putting more focus on successful COVID-19 vaccine developments after stocks took a hit this week, partly due to a steady uptick in COVID-19 cases across the globe.
In the scenario that Novavax succeeds in developing an effective COVID-19 vaccine candidate, it is at the ready to produce billions of doses.According to the company, it continued to scale up manufacturing capacity, and will be able to produce up to 2 billion annualized doses by mid-2021.
The firm has partnered with Endo International to help produce the clinical and market-ready vaccines, it announced Friday.Novavax CEO Stanley Ercksaid he expectsa Phase 3 trial of its COVID-19 vaccine candidate"to get underway very soon" in the US.
Shares of Novavax jumped as much as 10% to $112.45 in Friday pre-market trades. Shares of Novavax are up 2,474% year-to-date as investors pin hope on Novavax to develop a successful COVID-19 vaccine. Read more: Business Insider »
U.S. cannot shield Trump from rape accuser's defamation lawsuit, judge rules
A federal judge on Tuesday rejected a U.S. government request to drop Donald Trump as a defendant in a defamation lawsuit by a writer who said the president falsely denied raping her in a Manhattan department store a quarter century ago.
Novavax initiates late-stage COVID-19 vaccine trial in UK Novavax Inc on Thursday started a late-stage trial of its experimental COVID -19 vaccine in the United Kingdom in partnership with the government's Vaccines Taskforce, sending the company's shares up 6% after the bell. Let the clown 🤡test it first No way i will take the risk to inject a quickly made anti virus 🤞🏼
Novavax initiates late-stage COVID-19 vaccine trial in UK Novavax Inc on Thursday started a late-stage trial of its experimental COVID -19 vaccine in the United Kingdom in partnership with the government's Vaccines Taskforce, sending the company's shares up 6% after the bell. Label screams legit. Hit me with it. Is Fauci Giving Us All A Stall Job By Not Opening Up America Untill Syringes With Chips to Are Manufactured? Is Fauci Giving Us All A Stall Job By Not Opening Up America Untill Syringes With Chips to Are Manufactured? Do the math!
Mainland China reports seven new COVID-19 cases vs. 10 a day earlierMainland China reported seven new COVID -19 cases on Sept. 23, down from 10 reported a day earlier, the country's national health authority said on Thursday. 1.43 BILLION HUMANS 🤔. THX for 🤣the 🤣 update They must've been eating lots of soup Sounds legit
Johnson & Johnson Starts Its Phase 3 COVID-19 Vaccine TrialAs many as 60,000 adult volunteers in multiple countries will take part.
Single-dose COVID-19 vaccine enters Phase 3 trial and here's what that meansUnlike the other vaccine candidates that require two doses, the Johnson & Johnson vaccine is a single-dose, which may make it easier to distribute. We follow Our real FRONTLINE Physician Dr. SOLIMAN... New COVID19 CORONAVIRUS HOSPITAL TREATMENT modes LECTURE ... cheaper Steroids Dexamethasone ...cheaper Azithromycin Zinc Plaquenil or HYDROXYCHLOROQUINE works wonder Means people will soon become sick 🤡
Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflictNEW: A physician who heads the FDA vaccine advisory cmte. has recused herself from the panel's review of Covid-19 vaccines because of her role overseeing a clinical trial for Moderna Inc's candidate, her spokeswoman says.